A new economic evaluation by the Indian Council of Medical Research (ICMR) has found that six-month all-oral treatment regimens for multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) are not only more effective but also cost-saving in India. The findings strengthen the case for adopting shorter treatment protocols under the National TB Elimination…
